Background: One of the reversible effective contraceptives is intrauterine contraceptive devices (IUCDs).
However, the expensive cost in certain contexts and the fear of discomfort during insertion restrict its usage. Lack of training, concern of inflicting pain during the operation, and problems during the procedure that may result in insertion failure are among the barriers to its usage for healthcare professionals.
Aim and objectives: The goal of this research was to see how effective sublingual misoprostol before IUCD insertion was in reducing discomfort, complications, and facilitating IUCD insertion in women who had previously undergone CS but had never delivered vaginally.
Subjects and methods: The research was conducted at Bab ALsharia University Hospital's Department of Obstetrics & gynecology in a double-blind randomised controlled experiment. In this research, 600 participants were enrolled.
Results: In terms of insertion difficulties, there was a statistically significant difference between the two groups.
The insertion of an IUD was easier in the misoprostol group than in the placebo group. There were statistically significant differences between the two groups in terms of pain score, with the misoprostol collection having a lower discomfort score (5.73 1.34) than the placebo group (6.49 0.93), with a p-value of 0.001.
Conclusion: Our findings revealed that 200 ug sublingual misoprostol given 1 hours before IUD insertion in individuals who had a previous caesarean section (but no previous vaginal birth) simplified IUD installation and reduced the incidence of failure (primary outcome measure).